Logo

miRNA

Craif Raises $22M in Series C Round to Expand US, Japan Operations

The Nagoya University spinout will open an office in San Diego and is working toward FDA approval of its miSignal early cancer detection test.

AccuStem Sciences to Access Samples From Italian Trial to Validate Lung Cancer Screening Test

The firm is gearing up to launch its microRNA-based assay in the US in 2026 and hopes that data from the trial will help to demonstrate its added value.

Mirxes, Universiti Kebangsaan Malaysia Partner on Colorectal Cancer Detection Test

The partners aim to develop a blood-based colorectal cancer test for the Malaysian market using Mirxes' proprietary microRNA technology.

City of Hope, TGen Win $4.5M Grant to Advance Pancreatic Cancer Liquid Biopsy Screening

A City of Hope-led consortium aims to validate a noninvasive screening test for pancreatic ductal adenocarcinoma in a large-scale, diverse cohort. 

Aspira Women's Health Licenses Dana-Farber microRNA Signature; Firm Executes Reverse Stock Split

Aspira Women's Health has been evaluating Dana-Farber's microRNA technology for ovarian cancer detection since early 2021.